Nigeria: New Fulbright Scholar to Focus on AIDS in Her Homeland
November 9, 2004
Moji Adeyeye excelled in science in her homeland, earning a pharmacy degree from the University of Nigeria. In the United States, she earned her master's degree and doctorate in pharmaceutics at the University of Georgia. In January, Adeyeye, who has taught for 15 years at Pittsburgh's Duquesne University, will join five DU professors as part of a program to help Nigeria fight HIV/AIDS. She will return as a Fulbright scholar -- the exchange program sponsored by the U.S. Department of State.Adapted from:
"I met people crying out for help. My heart went out to them. Since my area of expertise is in drug formulation and manufacturing, I knew I had to do something," said Adeyeye, who will spend nine months in Nigeria.
Adeyeye will work with up to 24 HIV-negative volunteers in Nigeria to compare the efficacy of lamivudine and zidovudine. The study aims to help treat people with AIDS with less expensive, but effective, AIDS drugs. The study, a collaboration of the University of Lagos and National Institute for Pharmaceutical Research in Nigeria, will test the stability of the drugs in Nigeria's climate and examine their side effects and chemical similarities. Nigerian AIDS patients obtain medicines from the government, from pharmacies and from underground markets.
Adeyeye also helps Nigerian AIDS patients access treatment through Drugs for AIDS and HIV Patients, a nonprofit faith-based group she established. It collaborates with Nigerian hospitals linked with the Baptist AIDS Awareness and Prevention Program and Catholic hospitals. The group channels drug donations made by manufacturers; monitors drug storage; provides nutritional supplements for patients; and trains health care workers how to spread HIV/AIDS prevention and awareness messages.
11.08.04; Ervin Dyer
This article was provided by CDC National Prevention Information Network. It is a part of the publication CDC HIV/Hepatitis/STD/TB Prevention News Update.